Showing results (1-10 of 185) with videos related to
Sort By:
Pageof 19
Pharmaceutical Science & Technology Today|January 19, 2000
Percutaneous penetration enhancers: local versus transdermal activityAsbill, MichniakCritical Reviews in Therapeutic Drug Carrier Systems|February 24, 2001
Enhancement of transdermal drug delivery: chemical and physical approachesC S Asbill, A F El-Kattan, B MichniakInternational Journal of Pharmaceutics|April 18, 2000
The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systemsA F El-Kattan, C S Asbill, B B MichniakDrug Delivery|September 16, 2000
Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulationsA F El-Kattan, C S Asbill, N Kim, et al.International Journal of Pharmaceutics|March 16, 2001
The effects of terpene enhancers on the percutaneous permeation of drugs with different lipophilicitiesA F El-Kattan, C S Asbill, N Kim, et al.Pharmaceutical Research|November 22, 2000
Evaluation of a human bio-engineered skin equivalent for drug permeation studiesC Asbill, N Kim, A El-Kattan, et al.International Journal of Pharmaceutical Compounding|May 17, 2026
Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding FacilitiesHayden R Asbill, W Mark Moore, Scott AsbillJournal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2001
Evaluation of derivatives of 3-(2-oxo-1-pyrrolidine)hexahydro-1H-azepine-2-one as dermal penetration enhancers: side chain length variation and molecular modelingN Kim, A F El-Kattan, C S Asbill, et al.Pharmaceutical Science & Technology Today|December 16, 2000
Transdermal testing: practical aspects and methodsEl-Kattan, Asbill, HaidarInternational Journal of Pharmaceutical Compounding|August 23, 2013
The release and transdermal penetration of baclofen formulated in a poloxamer lecithin organogelJohn J Arnold, Scott AsbillPageof 19